We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Difficulty losing weight can happen even when a woman is making meaningful changes to nutrition, activity, and daily habits.
Weight is influenced by far more than willpower.
Appetite regulation, genetics, sleep, medications, medical conditions, metabolic health, age, muscle mass, stress, menstrual changes, and menopause can all affect how easily weight is gained, lost, or maintained.
A medical weight-loss approach looks beyond the scale to identify factors that may be making progress harder. Depending on the patient, care may include metabolic evaluation, nutritional support, physical-activity planning, medication management, and prescription weight-management treatment when medically appropriate.
Optimal Female Wellness provides individualized evaluation based on health history, symptoms, previous weight-loss efforts, medications, reproductive plans, and treatment goals.
Weight loss rarely happens at the same pace indefinitely.
As body weight decreases, several biological adaptations can make continued loss more difficult.
The body may:
A plateau does not automatically mean someone is doing something wrong.
It may mean that the current plan needs to be reassessed based on a smaller body size, changes in appetite, physical activity, medication response, or other factors.
Long-term weight management often requires a strategy that can adapt rather than a short-term diet that becomes progressively more restrictive.
Many women notice body-composition changes during perimenopause and after menopause.
Aging is an important contributor to midlife weight gain, while menopause appears to play an important role in redistributing fat toward the abdominal area. The Menopause Society notes that aging is the primary driver of midlife weight gain, while menopause can increase abdominal fat even when overall weight changes are modest.
This distinction matters.
Someone may notice:
without seeing a dramatic change on the scale.
Changes in visceral abdominal fat are also relevant to metabolic health because they are associated with insulin resistance and cardiovascular risk.
Hypothyroidism can contribute to weight gain or make weight management more difficult.
Other symptoms may include:
Hashimoto’s thyroiditis is a common cause of hypothyroidism.
When symptoms suggest thyroid dysfunction, testing may be appropriate.
However, thyroid hormone should not be prescribed simply because weight loss is difficult.
Once hypothyroidism is appropriately treated and thyroid levels are controlled, persistent weight concerns usually require evaluation of other factors as well.
Taking excessive thyroid hormone for weight loss can create risks for the heart, bones, and other systems.
An evaluation may be useful when:
Additional signs that may suggest a medical contributor include:
The goal is not to search indefinitely for a hidden hormone.
It is to identify conditions that would meaningfully change treatment.
Medical weight loss is a clinician-supervised approach to weight management.
It differs from a generic commercial diet because medical care may include:
The program should be individualized rather than assigning every patient the same calorie target, diet, or medication.
A useful plan also considers why previous approaches were difficult to maintain.
Prescription medication may be considered when a patient meets clinical criteria and the expected benefits outweigh the risks.
NIDDK notes that clinicians may consider chronic weight-management medication for adults with:
BMI is not the only consideration.
The decision should also review:
Weight medication should not be prescribed solely for cosmetic reasons.
Some weight-management medications act on hormone pathways involved in appetite and fullness.
FDA-approved chronic weight-management options include medications such as semaglutide and tirzepatide for qualifying patients. NIDDK explains that semaglutide acts on GLP-1 pathways involved in appetite, while tirzepatide acts on both GIP and GLP-1 pathways.
These medications may reduce:
They also have medication-specific risks, contraindications, and side effects.
Common gastrointestinal symptoms may include nausea, vomiting, diarrhea, or constipation depending on the medication.
Eligibility requires individual review.
Important considerations may include:
NIDDK advises that prescription weight-management medications should not be used during pregnancy or when planning pregnancy, and they are not recommended during breastfeeding.
Reproductive plans should therefore be discussed before treatment begins.
Medication is not a replacement for nutrition or activity.
NIDDK reports that prescription medications work best when used together with lifestyle and behavioral treatment.
That does not mean medication is unnecessary or that patients should have been able to succeed without it.
Medication treats biological pathways involved in appetite and weight regulation.
Nutrition, movement, sleep, and behavioral support address other parts of the same problem.
Combining them can provide a more complete treatment approach.
Obesity and chronic weight-management difficulties do not necessarily disappear because weight has been lost.
NIDDK notes that some weight regain is likely after weight-management medication is discontinued.
This should not automatically be interpreted as failure.
It reflects the fact that biological appetite and weight-regulation mechanisms may return when medication is removed.
For some patients, long-term treatment may be appropriate if the medication continues providing health benefits and is well tolerated.
Others may transition to another maintenance plan.
When hypothyroidism is present, appropriate thyroid hormone treatment can restore normal thyroid function.
This may help address a contributor to fatigue and weight changes.
However, increasing thyroid medication above what the body needs is not a safe weight-loss strategy.
Excess thyroid hormone can contribute to:
Thyroid treatment should aim for appropriate thyroid function, not an artificially elevated metabolism.
Weight-loss plateaus are frustrating, but they can be useful signals.
A plateau may prompt review of:
The response should not automatically be to eat dramatically less.
Sometimes the plan needs a small adjustment. Other times the body may simply need time to stabilize.
Regular follow-up makes these decisions more informed.
Difficulty losing weight can be influenced by biology, metabolic health, medications, sleep, PCOS, thyroid disease, menopause, muscle changes, stress, and many other factors.
The answer is not always a stricter diet or more intense exercise.
Optimal Female Wellness provides individualized evaluation and medical weight-management support that may include metabolic testing, nutrition guidance, physical-activity planning, medication review, and prescription weight-management treatment when appropriate.
Schedule an appointment to discuss your weight history, previous efforts, medications, symptoms, menopause or PCOS concerns, metabolic health, and which treatment options may best support sustainable progress.
Possible contributors include genetics, age, menopause-related body-composition changes, PCOS, insulin resistance, thyroid disease, medications, poor sleep, chronic stress, appetite regulation, and the body’s normal response to weight loss.
Midlife weight gain is strongly influenced by aging, while menopause can shift fat toward the abdominal area and may contribute to changes in body composition. Sleep disruption and loss of muscle may also affect weight management.
Medical weight loss is clinician-supervised weight management that may include health evaluation, nutritional support, physical activity, behavioral strategies, medication management, prescription treatment, and ongoing monitoring.
Weight-management medication may be considered for many adults with a BMI of 30 or greater, or a BMI of 27 or greater plus a weight-related health condition. Individual medication criteria and medical history still need to be reviewed.
GLP-1 and related medications may be considered for qualifying patients. Treatment depends on eligibility, medical history, current medications, possible side effects, pregnancy plans, and the specific medication being considered.
Hypothyroidism caused by Hashimoto’s may contribute to weight changes. Appropriate thyroid treatment restores thyroid hormone levels but should not be used as a weight-loss medication.
NIDDK reports that losing approximately 5% to 10% of starting body weight may improve blood glucose, blood pressure, and triglycerides in people with overweight or obesity.
Some weight regain is common after treatment stops because biological appetite and weight-regulation mechanisms remain active. Long-term maintenance planning is an important part of treatment.
No. Compounded products are not FDA-approved and do not undergo the same premarket review for safety, effectiveness, or quality. FDA has also reported dosing and sourcing concerns with some compounded GLP-1 products.
No. Pregnancy, breastfeeding, medication interactions, certain health conditions, and medication-specific risks may make some treatments inappropriate. Clinical evaluation is necessary before prescription weight-management treatment begins.